Raynaud M: On local asphyxia and symmetrical gangrene of the extremities [1862]. New researches on the nature and treatment of local asphyxia of the extremities [1874]. trans Selected monographs. Edited by: Barlow T. 1988, London: New Sydenham Society
Google Scholar
Allen EV, Brown GE: Raynaud's disease: a critical review of minimal requisites for diagnosis. Am J Med Sci. 1932, 183: 187-200. 10.1097/00000441-193202000-00004.
Article Google Scholar
Summers A: From white to blue to red: Raynaud's phenomenon. Emergency Nurse. 2005, 13: 18-20. 10.1016/j.aaen.2004.10.010.
Ho M, Belch JJ: Raynaud's phenomenon: state of the art 1998. Scandinavian Journal of Rheumatology. 1998, 27: 319-322. 10.1080/03009749850154311.
CAS Article PubMed Google Scholar
Wigley FM: Clinical practice. Raynaud's Phenomenon. New England Journal of Medicine. 2002, 347: 1001-1008. 10.1056/NEJMcp013013.
Article PubMed Google Scholar
DiMaio AM, Singh J: The infant with cyanosis in the emergency room. Pediatric Clinics of North America. 2006, 39: 987-1006.
Google Scholar
Charkoudian N: Skin blood flow in adult human thermoregulation: how it works, when it does not, and why. Mayo Clinic Proceedings. 2003, 78: 603-612. 10.4065/78.5.603.
Article PubMed Google Scholar
Krieger I, Brough AJ: Raynaud's phenomenon in an infant. Journal of Pediatrics. 1972, 80: 145-151. 10.1016/S0022-3476(72)80474-8.
CAS Article PubMed Google Scholar
De Angelis R, Del Medico P, Blasetti P, Cervini C: Raynaud's phenomenon: clinical spectrum of 118 patients. Clinical Rheumatology. 2003, 22: 279-284. 10.1007/s10067-003-0726-1.
Article PubMed Google Scholar
Nigrovic PA, Fuhlbrigge RC, Sundel RP: Raynaud's phenomenon in children: a retrospective review of 123 patients. Pediatrics. 2003, 111: 715-721. 10.1542/peds.111.4.715.
Article PubMed Google Scholar
Sheldon WB, Lurie DP, Maricq HR, Kahaleh MB, DeLustro FA, Gibofsky A, LeRoy EC: Three siblings with scleroderma (systemic sclerosis) and two with Raynaud's phenomenon from a single kindred. Arthritis & Rheumatism. 1981, 24: 668-676. 10.1002/art.1780240507.
CAS Article Google Scholar
Guntheroth WG, Morgan BC, Harbinson JA, Mullins GL: Raynaud's disease in children. Circulation. 1967, 36: 724-729.
CAS Article PubMed Google Scholar
Abuaf N, Laperche S, Carsique R, Meyer O, Deschamps A, Rajoely B, Johanet C, Homberg JC: Antimitochondrial antibodies in the antiphospholipid syndrome. Clinical Reviews in Allergy & Immunology. 1995, 13: 57-65. 10.1007/BF02772249.
CAS Article Google Scholar
Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G: Cryoglobulinaemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. GISC. Italian Group for the Study of Cryoglobulinaemias. Qjm. 1995, 88: 115-126.
CAS PubMed Google Scholar
Shero JH, Bordwell B, Rothfield NF, Earnshaw WC: High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients. Science. 4739, 231: 737-740.
Article Google Scholar
al-Awami M, Schillinger M, Maca T, Gschwandtner M, Bieglmayer C, Wagner O, Minar E: Homocysteine levels in patients with Raynaud's phenomenon. Vasa. 2002, 31: 87-90. 10.1024/0301-1526.31.2.87.
Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MI: Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Annals of the Rheumatic Diseases. 1996, 55: 122-127. 10.1136/ard.55.2.122.
PubMed Central CAS Article PubMed Google Scholar
Pistorius MA, Planchon B, Schott JJ, Lemarec H: Heredity and genetic aspects of Raynaud's disease. Journal des Maladies Vasculaires. 2006, 31: 10-15.
CAS Article PubMed Google Scholar
Rychlik-Golema W, Mastej K, Adamiec R: The role of endothelin-1 and selected cytokines in the pathogenesis of Raynaud's phenomenon associated with systemic connective tissue diseases. International Angiology. 2006, 25: 221-227.
CAS PubMed Google Scholar
Czupryniak A, Kaluzynska A, Nowicki M, Wiecek B, Bald E, Owczarek D: Raynaud's phenomenon and endothelial dysfunction in end-stage renal disease patients treated with hemodialysis. Kidney & Blood Pressure Research. 2005, 28: 27-31. 10.1159/000081059.
Article Google Scholar
Lazzerini PE, Capecchi PL, Bisogno S, Cozzalupi M, Rossi PC, Pasini FL: Homocysteine and Raynaud's phenomenon: a review. Autoimmunity Reviews. 2010, 9: 181-187. 10.1016/j.autrev.2009.08.004.
CAS Article PubMed Google Scholar
LeRoy EC, Medsger TA: Raynaud's phenomenon: a proposal for classification. Clinical & Experimental Rheumatology. 1992, 10: 485-488.
CAS Google Scholar
Harel L, Straussberg R, Rudich H, Cohen AH, Amir J: Raynaud's phenomenon as a manifestation of parvovirus B19 infection: case reports and review of parvovirus B19 rheumatic and vasculitic syndromes. Clinical Infectious Diseases. 2000, 30: 500-503. 10.1086/313712.
CAS Article PubMed Google Scholar
Toumbis-Ioannou E, Cohen PR: Chemotherapy-induced Raynaud's phenomenon. Cleveland Clinic Journal of Medicine. 1994, 61: 195-199.
Kallenberg CG: Raynaud's phenomenon as an early sign of connective tissue diseases. Vasa Supplementum. 1992, 34: 25-28.
CAS PubMed Google Scholar
Sayre JW: Raynaud's disease presenting in a 5-month-old-male infant. Pediatrics. 1973, 52: 412-415.
CAS PubMed Google Scholar
Cutolo M, Sulli A, Secchi ME, Paolino S, Pizzorni C: Nailfold capillaroscopy is useful for the diagnosis and follow-up of autoimmune rheumatic diseases. A future tool for the analysis of microvascular heart involvement?. Rheumatology. 2006, 45 (Suppl 4): iv43-46.
PubMed Google Scholar
Planchon B, Pistorius MA, Beurrier P, De Faucal P: Primary Raynaud's phenomenon. Age of onset and pathogenesis in a prospective study of 424 patients. Angiology. 1994, 45: 677-686. 10.1177/000331979404500802.
CAS Article PubMed Google Scholar
Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR: Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon. Clinical Rheumatology. 2006, 25: 153-158. 10.1007/s10067-005-1146-1.
Article PubMed Google Scholar
Allen E, Brown G: Raynaud's disease: A critical review of minimal requisites for diagnosis. Am J Med Sci. 1932, 183-187.
Duffy CM, Laxer RM, Lee P, Ramsay C, Fritzler M, Silverman ED: Raynaud syndrome in childhood. Journal of Pediatrics. 1989, 114: 73-78. 10.1016/S0022-3476(89)80604-3.
Calhoon MJ, Ross CN, Pounder E, Cassidy D, Manco-Johnson MJ, Goldenberg NA: High prevalence of thrombophilic traits in children with family history of thromboembolism. Journal of Pediatrics. 2010, 157: 485-489. 10.1016/j.jpeds.2010.03.031.
Article PubMed Google Scholar
Carmel R, Green R, Rosenblatt DS, Watkins D: Update on cobalamin, folate, and homocysteine. Hematology. 2003
Google Scholar
Virdis A, Iglarz M, Neves MF, Amiri F, Touyz RM, Rozen R, Schiffrin EL: Effect of hyperhomocystinemia and hypertension on endothelial function in methylenetetrahydrofolate reductase-deficient mice. Arteriosclerosis, Thrombosis & Vascular Biology. 2003, 23: 1352-1357. 10.1161/01.ATV.0000083297.47245.DA.
CAS Article Google Scholar
Tawakol A, Forgione MA, Stuehlinger M, Alpert NM, Cooke JP, Loscalzo J, Fischman AJ, Creager MA, Gewirtz H: Homocysteine impairs coronary microvascular dilator function in humans. Journal of the American College of Cardiology. 2002, 40: 1051-1058. 10.1016/S0735-1097(02)02069-7.
CAS Article PubMed Google Scholar
Cheng T-T, Chiu C-K: Elevated homocysteine levels in patients with Raynaud's phenomenon secondary to systemic lupus erythematosus. Clinical Rheumatology. 2002, 21: 251-254. 10.1007/s10067-002-8291-6.
Article PubMed Google Scholar
Kingma K, Wollersheim H, Thien T: Double-blind, placebo-controlled study of intravenous prostacyclin on hemodynamics in severe Raynaud's phenomenon: the acute vasodilatory effect is not sustained. Journal of Cardiovascular Pharmacology. 1995, 26: 388-393. 10.1097/00005344-199509000-00007.
CAS Article PubMed Google Scholar
Vinjar B, Stewart M: Oral vasodilators for primary Raynaud's phenomenon. Cochrane Database of Systematic Reviews. 2008, CD006687-
Google Scholar
van der Meer J, Wouda AA, Kallenberg CG, Wesseling H: A double-blind controlled trial of low dose acetylsalicylic acid and dipyridamole in the treatment of Raynaud's phenomenon. Vasa - Supplementum. 1987, 18: 71-75.
CAS PubMed Google Scholar
Denton CP, Howell K, Stratton RJ, Black CM: Long-term low molecular weight heparin therapy for severe Raynaud's phenomenon: a pilot study. Clinical & Experimental Rheumatology. 2000, 18: 499-502.
CAS Google Scholar
Ortensi A, Salsano F, Trinchi S, D'Orazi V, Pisarri S: Microsurgical distal sympathectomy in chronic vasospastic syndromes of the hand. International Surgery. 2005, 90: 88-92.
PubMed Google Scholar
Belch JJ, Ho M: Pharmacotherapy of Raynaud's phenomenon. Drugs. 1996, 52: 682-695. 10.2165/00003495-199652050-00006.
CAS Article PubMed Google Scholar
Schiopu E, Hsu VM, Impens AJ, Rothman JA, McCloskey DA, Wilson JE, Phillips K, Seibold JR: Randomized placebo-controlled crossover trial of tadalafil in Raynaud's phenomenon secondary to systemic sclerosis. Journal of Rheumatology. 2009, 36: 2264-2268. 10.3899/jrheum.090270.
CAS Article PubMed Google Scholar
Page 2
Type of acrocyanosis
Causes
Unilateral acrocyanosis
Local trauma/digital injury
Local infection: Paronechia
Raynaud's phenomenon
Thoracic outlet syndrome
Carpel Tunnel syndrome
Cervical tumors compressing neurovascular bundle* e.g. Neuroblastoma, stellate ganglion tumor
Thromboembolism of arteries of palmar arch
Frostbite
Reflex Sympathetic dystrophy
Bilateral acrocyanosis**
Benign acrocyanosis of infancy
Frostbite
Pernio
Raynaud's phenomenon
Reflex sympathetic dystrophy
Hypoxemia**
Congenital cyanotic heart disease**
Methemoglobinemia**
Purpura fulminans
Pheochromocytoma
*: Need to look for other signs of Horner's syndrome on the ipsilateral side of the face (ptosis, anhydrosis, miosis of pupil or unequal pupils, poor light reflex and enopthalmos);**: Need close clinical evaluation for presence of central cyanosis.